Giant-cell myocarditis management using short-term TandemHeart support, MANTA closure device, and combination immunosuppression.

Authors

Shazib Sagheer
Makoto Nagahama MD, Lehigh Valley Health NetworkFollow
Shane Prejean
Mustafa Ahmed
Manesh Kumar Gangwani
Silvio Litovsky
Andrew Lenneman
Indranee Rajapreyar
Jose A Tallaj
Joanna Joly

Publication/Presentation Date

1-1-2022

Abstract

We present the case of a 53-year-old woman who presented to the hospital with palpitations and fatigue. The workup revealed new-onset systolic heart failure secondary to giant cell myocarditis. She developed cardiogenic shock, which was managed with the TandemHeart left ventricular assist device and combination immunosuppression strategy. This article highlights our management approach that avoided the need for an urgent heart transplant.

Volume

35

Issue

2

First Page

214

Last Page

216

ISSN

0899-8280

Published In/Presented At

Sagheer, S., Nagahama, M., Prejean, S., Ahmed, M., Gangwani, M. K., Litovsky, S., Lenneman, A., Rajapreyar, I., Tallaj, J. A., & Joly, J. (2021). Giant-cell myocarditis management using short-term TandemHeart support, MANTA closure device, and combination immunosuppression. Proceedings (Baylor University. Medical Center), 35(2), 214–216. https://doi.org/10.1080/08998280.2021.1997047

Disciplines

Medicine and Health Sciences

PubMedID

35261455

Department(s)

Department of Medicine, Cardiology Division, Department of Medicine Fellows and Residents, Fellows and Residents

Document Type

Article